speb/financial-data huggingface dataset:
Financial ratios for ACR.OL — annual report dated 2023-12-31
Total revenue: 25221218.07465619
Gross profit: 12645677.799607074
Operating income: 4058840.864440079
Net income: 3028487.2298624753
Capital expenditures: 380550.09823182714
Operating cash flow: 8773182.711198429
Depreciation & amortization: 888998.0353634577
Net tangible assets: 35195088.4086444
Owner earnings: 3536935.166994106
Return on net tangible assets (%): 10.049513517134356
Capex to operating income (%): 9.375831941721726
Buffett classification: The Great
Stock price: 0.49901768172888017
P/E ratio: 137.81753506454754
Shares outstanding: 836400513
Book value: 41604616.89587426
P/B ratio: 10.03202711945884
Market cap (USD): 417378644.9941061
Debt to equity: 2.2460174483808895
Current ratio: 1.3931222750304413
Quick ratio: 1.3931222750304413
Effective tax rate (%): 19.002340903057654
COGS to revenue (%): 49.860955318751174
Free cash flow (dilution-adjusted): 8348428.2907662075
Buyback yield (%): 0
Retained earnings: 2660314.3418467585
Receivables turnover: 38.69077757685352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.983543180467573
FCF margin (%): 33.100813236118896
Revenue growth (%): 2.9582088608674977
Rule of 40 score: 36.059022096986396
Financial ratios for ACR.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3969465648854962
Shares outstanding: 836400513
Market cap (USD): 332006310.5038168
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACR.OL — quarterly report dated 2024-12-31
Total revenue: -3536981.465136805
Gross profit: -6796293.027360989
Operating income: -8618976.169461606
Net income: -7473168.5789938215
Capital expenditures: 84024.71315092675
Operating cash flow: 8811473.962930273
Depreciation & amortization: 401412.18005295674
Net tangible assets: 23830626.6548985
Owner earnings: -7155781.112091792
Return on net tangible assets (%): -30.027666564197915
Buffett classification: The Gruesome
Stock price: 0.3253968253968254
Shares outstanding: 836400513
Book value: 29273962.930273607
P/B ratio: 9.297069629374311
Market cap (USD): 272162071.6904762
Debt to equity: 2.6989121848562143
Current ratio: 2.3422352448723314
Quick ratio: 2.3422352448723314
Free cash flow (dilution-adjusted): 8722859.664607238
Buyback yield (%): 0
Retained earnings: -4629302.736098853
Receivables turnover: -5.184217335058215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.9401978768246035
Rule of 40 score: 0
Financial ratios for ACR.OL — annual report dated 2024-12-31
Total revenue: 11517299.20564872
Gross profit: -369461.60635481024
Operating income: -7705913.503971756
Net income: -6977934.686672551
Capital expenditures: 271050.3089143866
Operating cash flow: 12283671.668137688
Depreciation & amortization: 1020035.304501324
Net tangible assets: 23830626.6548985
Owner earnings: -6228949.691085613
Return on net tangible assets (%): -26.138421709549224
Buffett classification: The Gruesome
Stock price: 0.3253968253968254
Shares outstanding: 836400513
Book value: 29273962.930273607
P/B ratio: 9.297069629374311
Market cap (USD): 272162071.6904762
Debt to equity: 2.6989121848562143
Current ratio: 2.3422352448723314
Quick ratio: 2.3422352448723314
COGS to revenue (%): 103.20788406863308
Free cash flow (dilution-adjusted): 11978905.560458958
Buyback yield (%): 0
Retained earnings: -4629302.736098853
Receivables turnover: 16.88111254851229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.09904248952723
FCF margin (%): 104.00793924485212
Revenue growth (%): -54.33488116411791
Rule of 40 score: 49.673058080734215
Financial ratios for ACR.OL — quarterly report dated 2025-03-31
Total revenue: 6318606.870229008
Gross profit: 2728148.854961832
Operating income: 1167748.0916030535
Net income: 962786.2595419846
Capital expenditures: 72519.08396946565
Operating cash flow: 7223759.541984732
Depreciation & amortization: 196469.46564885497
Net tangible assets: 26398473.28244275
Owner earnings: 1086736.641221374
Return on net tangible assets (%): 4.116664738881499
Capex to operating income (%): 6.210165059650269
Buffett classification: The Great
Stock price: 0.42461832061068705
P/E ratio: 92.2195808436571
Shares outstanding: 836400513
Book value: 33142557.25190839
P/B ratio: 10.715859325174042
Market cap (USD): 355150981.18797714
Debt to equity: 2.470650728117605
Current ratio: 1.2720406399904658
Quick ratio: 1.2720406399904658
Effective tax rate (%): 24.998141678436035
COGS to revenue (%): 56.823570274392544
Free cash flow (dilution-adjusted): 7142080.152671755
Buyback yield (%): 0
Retained earnings: -4919942.748091603
Receivables turnover: 10.929031193266216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.015001924174264
FCF margin (%): 113.03251332699074
Rule of 40 score: 113.03251332699074
Financial ratios for ACR.OL — quarterly report dated 2025-06-30
Total revenue: 6337735.849056603
Gross profit: 2818669.314796425
Operating income: 1126017.874875869
Net income: 684607.7457795432
Capital expenditures: 92949.3545183714
Operating cash flow: -1384309.8311817278
Depreciation & amortization: 193843.09831181727
Net tangible assets: 27597020.854021847
Owner earnings: 785501.489572989
Return on net tangible assets (%): 2.846327122510813
Capex to operating income (%): 8.254696181321105
Buffett classification: The Great
Stock price: 0.7388282025819265
P/E ratio: 225.66071281984333
Shares outstanding: 836400513
Book value: 34485203.57497518
P/B ratio: 17.919461786411567
Market cap (USD): 617956287.6583912
Debt to equity: 2.570404243432988
Current ratio: 2.7871662923265004
Quick ratio: 2.7871662923265004
Effective tax rate (%): 22.469635627530362
COGS to revenue (%): 55.52561069240532
Free cash flow (dilution-adjusted): -1489275.0744786493
Buyback yield (%): 0
Retained earnings: -4435650.446871896
Receivables turnover: 14.088520971302428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9123650039346194
FCF margin (%): -23.498534964980177
Revenue growth (%): 0.3027404492867652
Rule of 40 score: -23.19579451569341
Financial ratios for ACR.OL — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7575150300601202
Shares outstanding: 836400513
Market cap (USD): 633585959.7474949
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACR.OL — quarterly report dated 2025-12-31
Total revenue: 6758308.457711442
Gross profit: 3281094.527363184
Operating income: 1519104.4776119401
Net income: 942985.0746268656
Capital expenditures: 132139.30348258704
Operating cash flow: 4476119.402985075
Depreciation & amortization: 162288.55721393033
Net tangible assets: 29742985.074626863
Owner earnings: 973134.328358209
Return on net tangible assets (%): 3.271811238571243
Capex to operating income (%): 8.698500032750376
Buffett classification: The Great
Stock price: 0.7749003984063746
P/E ratio: 250.205499175012
Shares outstanding: 836400513
Book value: 36592736.31840795
P/B ratio: 17.711905584523237
Market cap (USD): 648127090.7509961
Debt to equity: 2.2918693593867694
Current ratio: 0.8216946313626583
Quick ratio: 0.8216946313626583
Effective tax rate (%): 24.00160384923817
COGS to revenue (%): 51.45095036881082
Free cash flow (dilution-adjusted): 4340597.014925373
Buyback yield (%): 0
Retained earnings: -2557810.9452736317
Receivables turnover: 10.962072304712718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.327890839318859
FCF margin (%): 64.2260861883659
Rule of 40 score: 64.2260861883659
Financial ratios for ACR.OL — annual report dated 2025-12-31
Total revenue: 25836517.41293532
Gross profit: 13644577.114427859
Operating income: 5069552.23880597
Net income: 3585074.6268656715
Capital expenditures: 364676.61691542284
Operating cash flow: 14274527.363184078
Depreciation & amortization: 753432.8358208955
Net tangible assets: 29742985.074626863
Owner earnings: 3973830.8457711437
Return on net tangible assets (%): 13.36056497288545
Capex to operating income (%): 7.193467977781702
Buffett classification: The Great
Stock price: 0.7749003984063746
P/E ratio: 180.78482548008634
Shares outstanding: 836400513
Book value: 36592736.31840795
P/B ratio: 17.711905584523237
Market cap (USD): 648127090.7509961
Debt to equity: 2.2918693593867694
Current ratio: 0.8216946313626583
Quick ratio: 0.8216946313626583
Effective tax rate (%): 24.00016874789065
COGS to revenue (%): 47.18879136707271
Free cash flow (dilution-adjusted): 13878109.452736318
Buyback yield (%): 0
Retained earnings: -2557810.9452736317
Receivables turnover: 41.90719819238218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.431434490892549
FCF margin (%): 53.71509337318078
Revenue growth (%): 124.32791708896183
Rule of 40 score: 178.0430104621426
Financial ratios for AI1.AX — annual report dated 2021-06-30
Total revenue: 1308318.045112782
Gross profit: 1219859.3984962406
Operating income: -2741695.488721804
Net income: -2623544.3609022554
Capital expenditures: 1057014.2857142857
Depreciation & amortization: 405842.10526315786
Net tangible assets: 2178666.165413534
Owner earnings: -3274716.541353383
Return on net tangible assets (%): -150.30832136376466
Buffett classification: The Gruesome
Stock price: 0.21804511278195485
Shares outstanding: 1177021259
Book value: 1625109.022556391
P/B ratio: 157.92400977609364
Market cap (USD): 256643733.1654135
Debt to equity: 1.322469053551063
Current ratio: 1.035212114841264
Quick ratio: 0.8727834549664398
Interest coverage ratio: -37.025862068965516
COGS to revenue (%): 6.761249449014202
SG&A to revenue (%): 167.730363785679
Free cash flow (dilution-adjusted): -2171027.067669173
Buyback yield (%): 0
Retained earnings: -3022993.2330827066
Inventory turnover: 0.2895045080514981
Receivables turnover: 8.182178543718996
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -79.42482776917049
FCF margin (%): -165.94031365531018
Rule of 40 score: -165.94031365531018
Financial ratios for AI1.AX — annual report dated 2022-06-30
Total revenue: 3030293.7931034486
Gross profit: 1008015.1724137932
Operating income: -2904164.1379310344
Net income: -2992265.5172413792
Capital expenditures: 1580214.4827586208
Depreciation & amortization: 805246.8965517242
Net tangible assets: 1364031.7241379311
Owner earnings: -3767233.103448276
Return on net tangible assets (%): -276.1836866975487
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 1177021259
Book value: 90122.06896551698
P/B ratio: 450.355173060295
Market cap (USD): 40586939.96551724
Debt to equity: 28.06447194226995
Current ratio: 0.37315908769857065
Quick ratio: 0.33352906805018684
Interest coverage ratio: -19.492026902550002
COGS to revenue (%): 66.7353979106612
SG&A to revenue (%): 81.16520396565622
Free cash flow (dilution-adjusted): -2623133.103448276
Buyback yield (%): 0.22379035041711176
Retained earnings: -5810877.931034483
Inventory turnover: 23.755277953304493
Receivables turnover: 10.397880632970404
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -117.32234434173454
FCF margin (%): -86.56365628369707
Revenue growth (%): 131.61751872360867
Rule of 40 score: 45.0538624399116
Financial ratios for AI1.AX — annual report dated 2023-06-30
Total revenue: 1771666.8874172186
Gross profit: 954432.4503311259
Operating income: -1485370.1986754967
Net income: -1350521.8543046357
Capital expenditures: 140688.7417218543
Depreciation & amortization: 440155.62913907284
Net tangible assets: -188780.13245033112
Owner earnings: -1051054.9668874172
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 1177021259
Book value: 16307.947019866668
P/B ratio: 955.9563524873614
Market cap (USD): 15589685.549668875
Debt to equity: 152.5231675126986
Current ratio: 0.7502732784766659
Quick ratio: 0.7483164210873994
Interest coverage ratio: -5.939026521490457
COGS to revenue (%): 46.127996345717
SG&A to revenue (%): 78.07931094935475
Free cash flow (dilution-adjusted): -849266.8874172185
Buyback yield (%): 0.06824005886541085
Retained earnings: -6999600
Inventory turnover: 103.31748158070998
Receivables turnover: 6.696195117555625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -86.91407635031322
FCF margin (%): -47.936036590676565
Revenue growth (%): -41.53481449721805
Rule of 40 score: -89.47085108789462
Financial ratios for AI1.AX — annual report dated 2024-06-30
Total revenue: 3663622.6666666665
Gross profit: 2138220
Operating income: -1232202
Net income: -1036513.3333333334
Capital expenditures: 534147.3333333334
Depreciation & amortization: 666372.6666666666
Net tangible assets: 248651.33333333334
Owner earnings: -904288.0000000001
Return on net tangible assets (%): -363.6771168195358
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 1177021259
Book value: -791762
Market cap (USD): 15693616.786666667
Debt to equity: -2.387786565491482
Current ratio: 0.7047760103407092
Quick ratio: 0.6666864041342152
Interest coverage ratio: -5.485457610418287
COGS to revenue (%): 41.636456738448686
SG&A to revenue (%): 10.684979566672986
Free cash flow (dilution-adjusted): -533734.6666666666
Buyback yield (%): 0.045878525631625824
Retained earnings: -7883628
Inventory turnover: 15.532682999680944
Receivables turnover: 7.6158452504853935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -250.80065295178434
FCF margin (%): -14.56849449925156
Revenue growth (%): 106.78958853306726
Rule of 40 score: 92.2210940338157
Financial ratios for ALBFR.PA — annual report dated 2021-12-31
Total revenue: 37020332.95454545
Gross profit: 2088617.0454545454
Operating income: 5696672.7272727275
Net income: 5365417.045454546
Capital expenditures: 789772.7272727273
Operating cash flow: 8390909.090909092
Depreciation & amortization: 767768.1818181818
Net tangible assets: 2936604.5454545454
Owner earnings: 5343412.5
Return on net tangible assets (%): 181.95887179534807
Capex to operating income (%): 13.863754599973829
Buffett classification: The Great
Stock price: 194.88636363636363
P/E ratio: 51.860660666257616
Shares outstanding: 1427776
Book value: 26517286.363636367
P/B ratio: 10.493308738742119
Market cap (USD): 278254072.7272727
Debt to equity: 0.5617193021430446
Current ratio: 1.8028313279484334
Quick ratio: 1.8028313279484334
Effective tax rate (%): 6.277783121569577
Interest coverage ratio: 54.930551598693874
COGS to revenue (%): 94.35818946302021
Free cash flow (dilution-adjusted): 7601136.363636363
Buyback yield (%): 1.3783184681312188
Retained earnings: 5365417.045454546
Receivables turnover: 3.6209728798488383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.222034223344828
FCF margin (%): 20.532328471948755
Rule of 40 score: 20.532328471948755
Financial ratios for ALBFR.PA — annual report dated 2022-12-31
Total revenue: 39109847.872340426
Gross profit: 6090592.55319149
Operating income: 3993518.085106383
Net income: 3590240.425531915
Capital expenditures: 1041489.3617021277
Operating cash flow: 4292553.191489362
Depreciation & amortization: 874544.6808510639
Net tangible assets: 6673538.297872341
Owner earnings: 3423295.744680851
Return on net tangible assets (%): 51.29656251125834
Capex to operating income (%): 26.079495309819876
Buffett classification: The Good
Stock price: 159.5744680851064
P/E ratio: 63.45998282578124
Shares outstanding: 1427776
Book value: 28530985.106382973
P/B ratio: 7.985584615993826
Market cap (USD): 227836595.74468085
Debt to equity: 0.44638699262608345
Current ratio: 1.7461738243004508
Quick ratio: 1.7461738243004508
Effective tax rate (%): 10.711938594198282
Interest coverage ratio: 30.629636580231402
COGS to revenue (%): 84.42695923269258
Free cash flow (dilution-adjusted): 3251063.8297872343
Buyback yield (%): 0
Retained earnings: 3590240.425531915
Receivables turnover: 2.542938161444283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.26976265313205
FCF margin (%): 8.312647598116783
Revenue growth (%): 5.644235886156223
Rule of 40 score: 13.956883484273007
Financial ratios for ALBFR.PA — annual report dated 2023-12-31
Total revenue: 51339873.33333333
Gross profit: 12313134.444444444
Operating income: 6764088.888888889
Net income: 6251555.555555555
Capital expenditures: 3773333.333333333
Operating cash flow: 9663333.333333334
Depreciation & amortization: 1096312.2222222222
Net tangible assets: 6473218.888888889
Owner earnings: 3574534.444444444
Return on net tangible assets (%): 55.220354908437265
Capex to operating income (%): 55.78479814970563
Buffett classification: The Good
Stock price: 180
P/E ratio: 41.10971704820134
Shares outstanding: 1427776
Book value: 34784330.00000001
P/B ratio: 7.388375167783883
Market cap (USD): 256999680
Debt to equity: 0.327630765539157
Current ratio: 1.9631023221177741
Quick ratio: 1.9631023221177741
Effective tax rate (%): 9.016829390283284
Interest coverage ratio: 77.30779976125773
COGS to revenue (%): 76.01643002798389
Free cash flow (dilution-adjusted): 5890000
Buyback yield (%): 0
Retained earnings: 6251555.555555555
Receivables turnover: 5.430236925608179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.231745512859245
FCF margin (%): 11.47256433953025
Revenue growth (%): 31.270961474749985
Rule of 40 score: 42.74352581428023
Financial ratios for ALBFR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 8987881.25
Buffett classification: The Gruesome
Stock price: 233.33333333333334
Shares outstanding: 1427776
Book value: 41137191.66666667
P/B ratio: 8.098455918741818
Market cap (USD): 333147733.3333334
Debt to equity: 0.2000360885921762
Current ratio: 1.6997424840742417
Quick ratio: 1.6991980583840578
Buyback yield (%): 0
Retained earnings: 8225780.208333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALBFR.PA — annual report dated 2024-12-31
Total revenue: 59675544.79166667
Gross profit: 16578543.75
Operating income: 6057246.875
Net income: 8287637.5
Capital expenditures: 1041666.6666666667
Operating cash flow: 9965625
Depreciation & amortization: 1466666.6666666667
Net tangible assets: 8987881.25
Owner earnings: 8712637.5
Return on net tangible assets (%): 96.93761252130473
Capex to operating income (%): 17.19703172353639
Buffett classification: The Great
Stock price: 233.33333333333334
P/E ratio: 40.19815458064296
Shares outstanding: 1427776
Book value: 41137191.66666667
P/B ratio: 8.098455918741818
Market cap (USD): 333147733.3333334
Debt to equity: 0.2000360885921762
Current ratio: 1.6997424840742417
Quick ratio: 1.6991980583840578
Effective tax rate (%): -23.129689347214548
Interest coverage ratio: 116.88355778894471
COGS to revenue (%): 72.21886485012016
Free cash flow (dilution-adjusted): 8923958.333333334
Buyback yield (%): 0
Retained earnings: 8225780.208333334
Inventory turnover: 2964.1152743946127
Receivables turnover: 5.8249642094560246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.386989210204533
FCF margin (%): 14.954129643035133
Revenue growth (%): 16.236252481989002
Rule of 40 score: 31.190382125024136
Financial ratios for AMRN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.4
Shares outstanding: 20969109
Market cap (USD): 1413317946.6000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRN — annual report dated 2022-12-31
Total revenue: 392758510.6382979
Gross profit: 257961702.1276596
Operating income: -98237234.0425532
Net income: -112556382.9787234
Capital expenditures: 0
Operating cash flow: -191587234.04255322
Depreciation & amortization: 3293617.021276596
Net tangible assets: 610162765.9574468
Owner earnings: -109262765.95744681
Return on net tangible assets (%): -17.907150690520318
Buffett classification: The Gruesome
Stock price: 24.2
Shares outstanding: 20969109
Book value: 633332978.7234042
P/B ratio: 0.8012411398864165
Market cap (USD): 507452437.8
Debt to equity: 0.01682251781775914
Current ratio: 2.6556985343707966
Quick ratio: 1.774193672705691
Interest coverage ratio: -6156.2
COGS to revenue (%): 34.32053153770521
R&D to revenue (%): 8.237155092322986
SG&A to revenue (%): 82.45443440151898
Free cash flow (dilution-adjusted): -220110638.29787236
Buyback yield (%): 0
Retained earnings: -1624735106.382979
Inventory turnover: 0.5539627161918752
Receivables turnover: 2.818482326895183
Capitalized R&D asset: 32352127.65957447
ROCI (R&D-adjusted, %): -10.967553427046573
FCF margin (%): -56.04223265338184
Rule of 40 score: -56.04223265338184
Financial ratios for AMRN — annual report dated 2023-12-31
Total revenue: 341012222.2222222
Gross profit: 183934444.44444445
Operating income: -62906666.666666664
Net income: -65680000
Capital expenditures: 26666.666666666664
Operating cash flow: 7644444.444444444
Depreciation & amortization: 3294444.4444444445
Net tangible assets: 591992222.2222222
Owner earnings: -62412222.22222222
Return on net tangible assets (%): -10.542743617127101
Buffett classification: The Gruesome
Stock price: 17.4
Shares outstanding: 20969109
Book value: 613441111.111111
P/B ratio: 0.5947799878282258
Market cap (USD): 364862496.59999996
Debt to equity: 0.015825117687652716
Current ratio: 2.7961639482098297
Quick ratio: 1.798713345186808
Interest coverage ratio: -7077
COGS to revenue (%): 46.06221347556783
R&D to revenue (%): 7.239558047772807
SG&A to revenue (%): 65.14527012717042
Free cash flow (dilution-adjusted): -10332222.222222222
Buyback yield (%): 0
Retained earnings: -1762625555.5555556
Inventory turnover: 0.5466405790825006
Receivables turnover: 2.29787441132649
Capitalized R&D asset: 46363703.30969267
ROCI (R&D-adjusted, %): -8.387248337244516
Rosenberg metric: -2.288172773740496
FCF margin (%): -3.029868593826875
Revenue growth (%): -13.175090294537316
Rule of 40 score: -16.204958888364192
Financial ratios for AMRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.6
Shares outstanding: 20969109
Market cap (USD): 264210773.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.8
Shares outstanding: 20969109
Market cap (USD): 205497268.20000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRN — annual report dated 2024-12-31
Total revenue: 238139583.33333334
Gross profit: 84772916.66666667
Operating income: -95621875
Net income: -85607291.66666667
Capital expenditures: 0
Operating cash flow: -32312500
Depreciation & amortization: 3138541.666666667
Net tangible assets: 489361458.3333334
Owner earnings: -82468750
Return on net tangible assets (%): -16.85231817823822
Buffett classification: The Gruesome
Stock price: 9.8
Shares outstanding: 20969109
Book value: 506433333.3333334
P/B ratio: 0.40577358296583954
Market cap (USD): 205497268.20000002
Debt to equity: 0.015885193839268084
Current ratio: 3.3087096899677135
Quick ratio: 2.3859593551506264
Interest coverage ratio: -13113.857142857143
COGS to revenue (%): 64.40200512654519
R&D to revenue (%): 9.128487319236793
SG&A to revenue (%): 66.62321642594067
Free cash flow (dilution-adjusted): -50755208.333333336
Buyback yield (%): 0
Retained earnings: -1738068750
Inventory turnover: 0.8866833686644826
Receivables turnover: 1.8696096631473924
Capitalized R&D asset: 48955554.90543735
ROCI (R&D-adjusted, %): -17.40361464125539
Rosenberg metric: -4.0166242855214005
FCF margin (%): -21.313217913163673
Revenue growth (%): -30.166848043895456
Rule of 40 score: -51.480065957059125
Financial ratios for AMRN — quarterly report dated 2025-03-31
Total revenue: 45670652.17391304
Gross profit: 27315217.391304348
Operating income: -18211956.52173913
Net income: -17061956.52173913
Capital expenditures: 0
Operating cash flow: -13542391.304347826
Depreciation & amortization: 793478.2608695652
Net tangible assets: 497855434.7826087
Owner earnings: -16268478.260869564
Return on net tangible assets (%): -3.267711292129066
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 20969109
Book value: 514877173.9130434
P/B ratio: 0.36653786681922884
Market cap (USD): 188721981
Debt to equity: 0.01676212351193932
Current ratio: 3.5285269198561644
Quick ratio: 2.546494015073149
COGS to revenue (%): 40.19087512197444
R&D to revenue (%): 12.642501844491516
SG&A to revenue (%): 87.04333960063785
Free cash flow (dilution-adjusted): -18245652.173913043
Buyback yield (%): 0
Retained earnings: -1830698913.0434783
Inventory turnover: 0.10588124647313311
Receivables turnover: 0.3936608765716641
Capitalized R&D asset: 5773913.043478261
ROCI (R&D-adjusted, %): -2.6502547563318024
FCF margin (%): -39.95049622771735
Rule of 40 score: -39.95049622771735
Financial ratios for AMRN — quarterly report dated 2025-06-30
Total revenue: 85577647.05882353
Gross profit: 59249411.76470588
Operating income: 7969411.764705882
Net income: -16634117.647058824
Capital expenditures: 0
Operating cash flow: 19536470.588235296
Depreciation & amortization: 857647.0588235294
Net tangible assets: 529402352.9411765
Owner earnings: -15776470.588235294
Return on net tangible assets (%): -2.9800529787196215
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.22
Shares outstanding: 20969109
Book value: 546969411.7647059
P/B ratio: 0.6218244396568041
Market cap (USD): 340118947.97999996
Debt to equity: 0.01578322478512617
Current ratio: 3.2634151850537254
Quick ratio: 2.3424811504415257
COGS to revenue (%): 30.76531804621878
R&D to revenue (%): 6.756849644629575
SG&A to revenue (%): 53.165340042067065
Free cash flow (dilution-adjusted): 12431764.705882356
Buyback yield (%): 0
Retained earnings: -1998096470.5882354
Inventory turnover: 0.13068487071079862
Receivables turnover: 0.6106018635104508
Capitalized R&D asset: 9650874.680306906
ROCI (R&D-adjusted, %): 1.7089786764956543
Rosenberg metric: 5.530771615875266
FCF margin (%): 14.52688305082416
Revenue growth (%): 87.37995405221137
Rule of 40 score: 101.90683710303554
Financial ratios for AMRN — quarterly report dated 2025-09-30
Total revenue: 58435294.11764706
Gross profit: 26127058.82352941
Operating income: -1996470.5882352942
Net income: -9103529.411764706
Capital expenditures: 0
Operating cash flow: -14937647.05882353
Depreciation & amortization: 1020000
Net tangible assets: 523327058.8235294
Owner earnings: -8083529.411764706
Return on net tangible assets (%): -1.5446419739764583
Buffett classification: The Gruesome
Stock price: 16.38
Shares outstanding: 20969109
Book value: 539875294.1176472
P/B ratio: 0.6362098972900058
Market cap (USD): 343474005.41999996
Debt to equity: 0.014667875369911132
Current ratio: 3.447970455405991
Quick ratio: 2.43441637903124
COGS to revenue (%): 55.28890678477955
R&D to revenue (%): 8.47191463660157
SG&A to revenue (%): 39.65572780350312
Free cash flow (dilution-adjusted): -17238823.529411763
Buyback yield (%): 0
Retained earnings: -2007200000
Inventory turnover: 0.14868193803024315
Receivables turnover: 0.39015309208304205
Capitalized R&D asset: 10730156.010230178
ROCI (R&D-adjusted, %): -0.4450246072478061
Rosenberg metric: -5.728179043743642
FCF margin (%): -29.50070465069458
Revenue growth (%): -31.716638484486047
Rule of 40 score: -61.21734313518063
Financial ratios for AMRN — annual report dated 2025-12-31
Total revenue: 251348235.29411766
Gross profit: 142197647.05882353
Operating income: -16401176.470588235
Net income: -45644705.88235294
Capital expenditures: 0
Operating cash flow: 7915294.117647059
Depreciation & amortization: 3562352.941176471
Net tangible assets: 524607058.8235294
Owner earnings: -42082352.94117647
Return on net tangible assets (%): -8.021690183801432
Buffett classification: The Gruesome
Stock price: 13.96
Shares outstanding: 20969109
Book value: 540330588.2352942
P/B ratio: 0.5417586344612557
Market cap (USD): 292728761.64000005
Debt to equity: 0.013238083003651356
Current ratio: 3.3420001131343886
Quick ratio: 2.334538385983678
Interest coverage ratio: -1991.5714285714284
COGS to revenue (%): 43.42604120835401
R&D to revenue (%): 9.27047545940481
SG&A to revenue (%): 53.82876346854142
Free cash flow (dilution-adjusted): -8481176.470588235
Buyback yield (%): 0
Retained earnings: -2008640000
Inventory turnover: 0.4735746005818999
Receivables turnover: 1.6844802573483035
Capitalized R&D asset: 46012966.05392157
ROCI (R&D-adjusted, %): -2.69507093588372
Rosenberg metric: 2.641609141620134
FCF margin (%): -3.3742733306497663
Revenue growth (%): 5.546600769136161
Rule of 40 score: 2.1723274384863944
Financial ratios for AMRN — quarterly report dated 2025-12-31
Total revenue: 57904705.88235294
Gross profit: 27257647.05882353
Operating income: -2660000
Net income: -1440000
Capital expenditures: 0
Operating cash flow: 17974117.647058822
Depreciation & amortization: 825882.3529411765
Net tangible assets: 524607058.8235294
Owner earnings: -614117.6470588235
Return on net tangible assets (%): -0.11706240637250065
Buffett classification: The Gruesome
Stock price: 13.96
Shares outstanding: 20969109
Book value: 540330588.2352942
P/B ratio: 0.5417586344612557
Market cap (USD): 292728761.64000005
Debt to equity: 0.013238083003651356
Current ratio: 3.3420001131343886
Quick ratio: 2.334538385983678
COGS to revenue (%): 52.926715292874704
R&D to revenue (%): 10.912452508177736
SG&A to revenue (%): 40.754586643369436
Free cash flow (dilution-adjusted): 16074117.647058822
Buyback yield (%): 0
Retained earnings: -2008640000
Inventory turnover: 0.13296922056046143
Receivables turnover: 0.3880645263025104
Capitalized R&D asset: 11543894.11764706
ROCI (R&D-adjusted, %): -0.3540903292246717
Rosenberg metric: 0.22837452471482908
FCF margin (%): 27.75960503057762
Revenue growth (%): -0.9079927521642858
Rule of 40 score: 26.851612278413334
Financial ratios for ARBK — annual report dated 2021-12-31
Capital expenditures: 254295945.94594595
Buffett classification: The Gruesome
Stock price: 2626.56
Shares outstanding: 14634897
Market cap (USD): 38439435064.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARBK — annual report dated 2022-12-31
Total revenue: 70581927.71084338
Gross profit: 13680722.891566265
Operating income: -45987951.807228915
Net income: -275856626.5060241
Capital expenditures: 115232530.12048194
Operating cash flow: -121972289.15662651
Depreciation & amortization: 34943373.49397591
Net tangible assets: 27078313.25301205
Owner earnings: -356145783.13253015
Return on net tangible assets (%): -1315.2436040044495
Buffett classification: The Gruesome
Stock price: 233.28
Shares outstanding: 14634897
Book value: 29612048.192771092
P/B ratio: 115.29188220737242
Market cap (USD): 3414028772.16
Debt to equity: 3.0871104239563834
Current ratio: 1.2780271154745206
Quick ratio: 1.2780271154745206
Interest coverage ratio: -1.684391686156833
COGS to revenue (%): 80.6172439103494
R&D to revenue (%): 0.1879865489988563
SG&A to revenue (%): 60.36904904153081
Free cash flow (dilution-adjusted): -259493975.90361446
Buyback yield (%): 0
Retained earnings: -189562650.60240966
Receivables turnover: 71.18226002430134
Capitalized R&D asset: 132684.53012048194
ROCI (R&D-adjusted, %): -42.827702650481655
FCF margin (%): -367.64931806155363
Rule of 40 score: -367.64931806155363
Financial ratios for ARBK — annual report dated 2023-12-31
Total revenue: 73064556.96202531
Gross profit: 3925316.4556962023
Operating income: -20827848.10126582
Net income: -43844303.79746835
Capital expenditures: 1407594.9367088608
Operating cash flow: -60703797.46835443
Depreciation & amortization: 25479746.83544304
Net tangible assets: -924050.6329113924
Owner earnings: -19772151.89873417
Buffett classification: The Gruesome
Stock price: 807.84
Shares outstanding: 14634897
Book value: 200000
P/B ratio: 59113.2759624
Market cap (USD): 11822655192.48
Debt to equity: 395.67721518987344
Current ratio: 0.5410186695667936
Quick ratio: 0.5410186695667936
Interest coverage ratio: -1.4238490827275874
COGS to revenue (%): 94.62760520434503
R&D to revenue (%): 0
SG&A to revenue (%): 27.22406056721124
Free cash flow (dilution-adjusted): -67037974.6835443
Buyback yield (%): 0
Retained earnings: -243005063.29113922
Receivables turnover: 23.27459677419355
Capitalized R&D asset: 88898.63518072291
ROCI (R&D-adjusted, %): -34.050308663951
Rosenberg metric: -73.52331448897495
FCF margin (%): -91.75170215346235
Revenue growth (%): 3.517372409198918
Rule of 40 score: -88.23432974426343
Financial ratios for ARBK — quarterly report dated 2024-09-30
Total revenue: 9944000
Gross profit: -2266666.6666666665
Operating income: -4808000
Net income: -8370666.666666667
Capital expenditures: 0
Operating cash flow: 35913333.333333336
Depreciation & amortization: 3290666.6666666665
Net tangible assets: -26685333.333333332
Owner earnings: -5080000
Buffett classification: The Gruesome
Stock price: 261.36
Shares outstanding: 14634897
Book value: -26366666.666666664
Market cap (USD): 3824976679.92
Debt to equity: -2.0152718078381797
Current ratio: 0.5191890617633191
Quick ratio: 0.5191890617633191
Interest coverage ratio: -2.497229916897507
COGS to revenue (%): 122.79431482971306
SG&A to revenue (%): -15.835344596406545
Free cash flow (dilution-adjusted): 37486666.66666667
Buyback yield (%): 0
Retained earnings: -307504000
Receivables turnover: 2.511111111111111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.121858097359212
FCF margin (%): 376.97774202198985
Rule of 40 score: 376.97774202198985
Financial ratios for ARBK — quarterly report dated 2024-12-31
Total revenue: 14752500
Gross profit: 1703750
Operating income: -1586250
Net income: -19918750
Capital expenditures: 3750
Operating cash flow: -57218750
Depreciation & amortization: 2908750
Net tangible assets: -37076250
Owner earnings: -17013750
Buffett classification: The Gruesome
Stock price: 122.04
Shares outstanding: 14634897
Book value: -36856250
Market cap (USD): 1786042829.88
Debt to equity: -1.36208241478718
Current ratio: 1.240703464350037
Quick ratio: 1.240703464350037
Interest coverage ratio: -1.187090739008419
COGS to revenue (%): 88.45110998135908
SG&A to revenue (%): 81.91831892899508
Free cash flow (dilution-adjusted): -58900000
Buyback yield (%): 0
Retained earnings: -308845000
Receivables turnover: 4.815177478580171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.923923006416132
FCF margin (%): -399.254363667175
Revenue growth (%): 48.35579243765085
Rule of 40 score: -350.8985712295242
Financial ratios for ARBK — annual report dated 2024-12-31
Total revenue: 60643750
Gross profit: 1821250
Operating income: -16166250
Net income: -68877500
Capital expenditures: 1113750
Operating cash flow: -55997500
Depreciation & amortization: 18636250
Net tangible assets: -37076250
Owner earnings: -51355000
Buffett classification: The Gruesome
Stock price: 122.04
Shares outstanding: 14634897
Book value: -36856250
Market cap (USD): 1786042829.88
Debt to equity: -1.36208241478718
Current ratio: 1.240703464350037
Quick ratio: 1.240703464350037
Interest coverage ratio: -1.8991189427312776
COGS to revenue (%): 96.99680511182109
SG&A to revenue (%): 24.9036380500876
Free cash flow (dilution-adjusted): -60696250
Buyback yield (%): 0
Retained earnings: -308845000
Receivables turnover: 19.793961648306812
Capitalized R&D asset: 43785.89493975904
ROCI (R&D-adjusted, %): -131.6048787271353
FCF margin (%): -100.08657116355766
Revenue growth (%): -16.999770447497443
Rule of 40 score: -117.0863416110551
Financial ratios for ARBK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -51471232.87671233
Buffett classification: The Gruesome
Stock price: 40.39
Shares outstanding: 14634897
Book value: -51331506.84931506
Market cap (USD): 591103489.83
Debt to equity: -1.0742954739538857
Current ratio: 0.7450980392156863
Quick ratio: 0.7450980392156863
Buyback yield (%): 0
Retained earnings: -349594520.5479452
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBAR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.28
Shares outstanding: 204236693
Market cap (USD): 465659660.03999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBAR — annual report dated 2022-12-31
Total revenue: 14936957868.24993
Net income: 2256250958.4393554
Capital expenditures: 629236437.6590331
Operating cash flow: 4333759010.460843
Depreciation & amortization: 393779332.7678824
Net tangible assets: 6099232671.755726
Owner earnings: 2020793853.5482047
Return on net tangible assets (%): 33.13193580736933
Buffett classification: The Gruesome
Stock price: 3.07
P/E ratio: 0.2778975650579665
Shares outstanding: 204236693
Book value: 6363726649.703136
P/B ratio: 0.09852821813759857
Market cap (USD): 627006647.51
Debt to equity: 0.06669332841529821
Effective tax rate (%): -4.552470935649714
COGS to revenue (%): 0
SG&A to revenue (%): 31.753070214522584
Free cash flow (dilution-adjusted): 3704522572.80181
Buyback yield (%): 0
Retained earnings: -810079236.6412214
Receivables turnover: 23.797892894495643
Capitalized R&D asset: 0
FCF margin (%): 24.801051227948907
Rule of 40 score: 24.801051227948907
Financial ratios for BBAR — annual report dated 2023-12-31
Total revenue: 6766669589.5938015
Net income: 557537538.0578727
Capital expenditures: 149433456.27367014
Operating cash flow: 2131609667.318498
Depreciation & amortization: 98846892.24980816
Net tangible assets: 3675298513.577069
Owner earnings: 506950974.0340107
Return on net tangible assets (%): 13.79346390942838
Buffett classification: The Gruesome
Stock price: 4.52
P/E ratio: 1.6557626874339295
Shares outstanding: 204236693
Book value: 3813035906.829376
P/B ratio: 0.24210363471966867
Market cap (USD): 923149852.3599999
Debt to equity: 0.04552391730285811
Effective tax rate (%): 49.81082228597495
COGS to revenue (%): 0
SG&A to revenue (%): 23.583016821877013
Free cash flow (dilution-adjusted): 1982176211.0448277
Buyback yield (%): 0
Retained earnings: -457072798.83165425
Receivables turnover: 5.898766160464883
Capitalized R&D asset: 0
FCF margin (%): 29.293231844704515
Revenue growth (%): -54.69847575872817
Rule of 40 score: -25.405243914023657
Financial ratios for BBAR — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 19263893.290251758
Buffett classification: The Gruesome
Stock price: 10.23
Shares outstanding: 204236693
Market cap (USD): 2089341369.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBAR — quarterly report dated 2024-12-31
Total revenue: 709175960.7363868
Net income: 90803830.336185
Capital expenditures: 126773586.29653339
Operating cash flow: 65618068.24574676
Depreciation & amortization: 28412416.34173311
Net tangible assets: 3195659522.978137
Owner earnings: -7557339.618615285
Return on net tangible assets (%): -0.23648763468932882
Buffett classification: The Gruesome
Stock price: 18.8
P/E ratio: 10.571277153684985
Shares outstanding: 204236693
Book value: 3337669048.866129
P/B ratio: 1.150398608185675
Market cap (USD): 3839649828.4
Debt to equity: 0.13341667713734373
Effective tax rate (%): -133.97208238226474
COGS to revenue (%): 0
SG&A to revenue (%): 42.91420843976941
Free cash flow (dilution-adjusted): -61155518.05078663
Buyback yield (%): 0
Retained earnings: 1983646995.0920484
Receivables turnover: 1.7087956922467755
Capitalized R&D asset: 0
FCF margin (%): -8.623461797447927
Rule of 40 score: -8.623461797447927
Financial ratios for BBAR — annual report dated 2024-12-31
Total revenue: 4373540469.262256
Net income: 465486989.07835263
Capital expenditures: 209926501.96900037
Operating cash flow: 3303883629.168364
Depreciation & amortization: 101580639.77962714
Net tangible assets: 3195659522.978137
Owner earnings: 357141126.88897943
Return on net tangible assets (%): 11.175819085887731
Buffett classification: The Gruesome
Stock price: 18.8
P/E ratio: 8.24867272015995
Shares outstanding: 204236693
Book value: 3337669048.866129
P/B ratio: 1.150398608185675
Market cap (USD): 3839649828.4
Debt to equity: 0.13341667713734373
Effective tax rate (%): 17.290455226216757
COGS to revenue (%): 0
SG&A to revenue (%): 28.16859722642161
Free cash flow (dilution-adjusted): 3093957127.1993637
Buyback yield (%): 0
Retained earnings: 1983646995.0920484
Receivables turnover: 10.538269100354222
Capitalized R&D asset: 0
FCF margin (%): 70.74262028541978
Revenue growth (%): -35.36642492507461
Rule of 40 score: 35.376195360345164
Financial ratios for BBAR — quarterly report dated 2025-03-31
Total revenue: 861596187.7603092
Net income: 101513076.43240404
Capital expenditures: 17030907.845859442
Operating cash flow: -488964432.8543019
Depreciation & amortization: 25883644.1409328
Net tangible assets: 2523963198.379048
Owner earnings: 110365812.7274774
Return on net tangible assets (%): 4.37271877808508
Buffett classification: The Gruesome
Stock price: 17.87
P/E ratio: 8.988274792214293
Shares outstanding: 204236693
Book value: 2642756490.375597
P/B ratio: 1.381023835227169
Market cap (USD): 3649709703.9100003
Debt to equity: 0.20353569989532275
Effective tax rate (%): 38.10264652554152
COGS to revenue (%): 0
SG&A to revenue (%): 36.70337159878759
Free cash flow (dilution-adjusted): -505995340.70016134
Buyback yield (%): 0
Retained earnings: 433326887.3588233
Receivables turnover: 2.9576922261978162
Capitalized R&D asset: 0
FCF margin (%): -58.72766707748318
Revenue growth (%): 21.49258230152837
Rule of 40 score: -37.23508477595482
Financial ratios for BBAR — quarterly report dated 2025-06-30
Total revenue: 669127826.1162537
Net income: 50214719.9784372
Capital expenditures: 28408808.739671335
Operating cash flow: 471167424.17223287
Depreciation & amortization: 20919542.127473194
Net tangible assets: 2350473316.88047
Owner earnings: 42725453.366239056
Return on net tangible assets (%): 1.817738285280513
Buffett classification: The Gruesome
Stock price: 16.23
P/E ratio: 13.667337212261717
Shares outstanding: 204236693
Book value: 2472227175.0208454
P/B ratio: 1.3407997294431693
Market cap (USD): 3314761527.39
Debt to equity: 0.2851512827473476
Effective tax rate (%): 33.65548595838471
COGS to revenue (%): 0
SG&A to revenue (%): 34.63654559573018
Free cash flow (dilution-adjusted): 442758615.4325615
Buyback yield (%): 0
Retained earnings: 116661285.51333776
Receivables turnover: 3.5339028700442334
Capitalized R&D asset: 0
FCF margin (%): 66.16951173625785
Revenue growth (%): -22.3385809243621
Rule of 40 score: 43.83093081189575
Financial ratios for BBAR — quarterly report dated 2025-09-30
Total revenue: 623244381.1164867
Net income: 28034597.683374938
Capital expenditures: 39241270.68283739
Operating cash flow: 178704622.94092092
Depreciation & amortization: 20278459.657881755
Net tangible assets: 2075344044.5946643
Owner earnings: 9071786.658419304
Return on net tangible assets (%): 0.43712206089622674
Buffett classification: The Gruesome
Stock price: 8.21
P/E ratio: 6.197311778511829
Shares outstanding: 204236693
Book value: 2196356299.2908745
P/B ratio: 0.7634386324620345
Market cap (USD): 1676783249.5300002
Debt to equity: 0.33150441125439883
Effective tax rate (%): 37.94751505488854
COGS to revenue (%): 0
SG&A to revenue (%): 32.771813643734674
Free cash flow (dilution-adjusted): 139463352.25808352
Buyback yield (%): 0
Retained earnings: 133913490.327759
Receivables turnover: 3.145320959367595
Capitalized R&D asset: 0
FCF margin (%): 22.376993115966386
Revenue growth (%): -6.857201749639286
Rule of 40 score: 15.5197913663271
Financial ratios for BBAR — annual report dated 2025-12-31
Total revenue: 2104262136.8386967
Net income: 229125024.6298631
Capital expenditures: 149386969.9412328
Operating cash flow: 689149261.793054
Depreciation & amortization: 76544141.53731683
Net tangible assets: 2282442080.2072353
Owner earnings: 156282196.22594714
Return on net tangible assets (%): 6.847148393432942
Buffett classification: The Gruesome
Stock price: 17.82
P/E ratio: 15.884331600790341
Shares outstanding: 204236693
Book value: 2441183799.40613
P/B ratio: 1.4908741693867482
Market cap (USD): 3639497869.26
Debt to equity: 0.4210023504474284
Effective tax rate (%): 36.02138018685904
COGS to revenue (%): 0
SG&A to revenue (%): 38.93278739068448
Free cash flow (dilution-adjusted): 539762291.8518212
Buyback yield (%): 0
Retained earnings: 1545048789.8642085
Receivables turnover: 15.846613366842085
Capitalized R&D asset: 0
FCF margin (%): 25.650905483796997
Revenue growth (%): -51.88652873735381
Rule of 40 score: -26.23562325355681
Financial ratios for BBAR — quarterly report dated 2025-12-31
Total revenue: 402729929.2451205
Net income: 96210844.71818614
Capital expenditures: 76928009.14921908
Operating cash flow: 495685220.0152946
Depreciation & amortization: 26165202.65382469
Net tangible assets: 2282442080.2072353
Owner earnings: 45448038.222791746
Return on net tangible assets (%): 1.9912022573061425
Buffett classification: The Gruesome
Stock price: 17.82
P/E ratio: 13.187865189109923
Shares outstanding: 204236693
Book value: 2441183799.40613
P/B ratio: 1.4908741693867482
Market cap (USD): 3639497869.26
Debt to equity: 0.4210023504474284
Effective tax rate (%): 35.086531479258575
COGS to revenue (%): 0
SG&A to revenue (%): 57.23719423000744
Free cash flow (dilution-adjusted): 418757210.8660756
Buyback yield (%): 0
Retained earnings: 1545048789.8642085
Receivables turnover: 3.032847176346025
Capitalized R&D asset: 0
FCF margin (%): 103.97965993016626
Revenue growth (%): -35.381699146061166
Rule of 40 score: 68.5979607841051
Financial ratios for BGI — annual report dated 2022-03-31
Total revenue: 145073600
Gross profit: 60976000
Operating income: 3575200
Net income: 1029600
Capital expenditures: 3689600
Operating cash flow: 14918400
Depreciation & amortization: 4647200
Net tangible assets: -133600
Owner earnings: 1987200
Return on net tangible assets (%): -1487.4251497005987
Capex to operating income (%): 103.19982098903557
Buffett classification: The Gruesome
Stock price: 5.19
P/E ratio: 59.868066462703965
Shares outstanding: 11876717
Book value: 4691200
P/B ratio: 13.139529593707369
Market cap (USD): 61640161.230000004
Debt to equity: 23.938778990450206
Current ratio: 1.0213658865886588
Quick ratio: 0.13357335733573358
Effective tax rate (%): 0
Interest coverage ratio: 1.4044626021370208
COGS to revenue (%): 57.968920603059416
SG&A to revenue (%): 36.363335575873215
Free cash flow (dilution-adjusted): 10269600
Buyback yield (%): 0
Retained earnings: -90730400
Inventory turnover: 1.332226545173432
Receivables turnover: 22.563394301356226
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.735063201279919
FCF margin (%): 7.078889611893549
Rule of 40 score: 7.078889611893549
Financial ratios for BGI — annual report dated 2023-03-31
Total revenue: 120703703.7037037
Gross profit: 50340740.74074074
Operating income: -2820740.7407407407
Net income: -5505185.185185185
Capital expenditures: 6205925.925925925
Operating cash flow: -5129629.62962963
Depreciation & amortization: 4202222.222222222
Net tangible assets: -5631111.111111111
Owner earnings: -7508888.888888888
Buffett classification: The Gruesome
Stock price: 8.11
Shares outstanding: 11876717
Book value: -446666.66666665673
Market cap (USD): 96320174.86999999
Debt to equity: -251.9900497512494
Current ratio: 0.9253326432083672
Quick ratio: 0.13683214792471687
Interest coverage ratio: -0.6823149973123097
COGS to revenue (%): 58.2939552009819
SG&A to revenue (%): 40.56152193924517
Free cash flow (dilution-adjusted): -12102962.962962963
Buyback yield (%): 0
Retained earnings: -89514814.8148148
Inventory turnover: 1.075070452822074
Receivables turnover: 14.322756438428408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.484009231783713
FCF margin (%): -10.027002147898129
Revenue growth (%): -16.79829844733728
Rule of 40 score: -26.82530059523541